AplidinTM Induces Apoptosis in Human Cancer Cells via Glutathione Depletion and Sustained Activation of the Epidermal Growth Factor Receptor, Src, JNK, and p38 MAPK

This publication has 52 references indexed in Scilit:

• Phase I (PI) trials with aplidine (APL), a new marine derived anticancer compound
  European Journal Of Cancer, 2001
• Antiproliferative effect of dehydrodidemnin B (DDB), a depsipeptide isolated from Mediterranean tunicates
  Published by Elsevier ,1999
• In vitro activity of aplidine, a new marine-derived anti-cancer compound, on freshly explanted clonogenic human tumour cells and haematopoietic precursor cells
  British Journal of Cancer, 1998
• Polyamine contents of human breast cancer cells treated with the cytotoxic agents chlorpheniramine and dehydrodidemnin B
  Cancer Letters, 1997
• The Role of c-Jun N-terminal Kinase (JNK) in Apoptosis Induced by Ultraviolet C and γ Radiation
  Journal of Biological Chemistry, 1996
• Adriamycin activates c-jun N-terminal kinase in human leukemia cells: a relevance to apoptosis
  Cancer Letters, 1996
• Structure−Activity Relationships of the Didemnins
  Journal of Medicinal Chemistry, 1996
• Apoptosis in the Pathogenesis and Treatment of Disease
  Science, 1995
• Apoptosis in cancer therapy: Crossing the threshold
  Cell, 1994
• p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
  Cell, 1993